Sponsor Pipeline

Nurix Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
4
Recruiting
1
Phase 3
10
Disease Areas
7
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-05 NCT07221500
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine…		 Trial sites expanded: 32 -> 35 locations
2026-07-29 NCT06717269
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and…		 Trial completed
2026-07-29 NCT06717269
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and…		 Primary endpoint(s) modified
2026-07-29 NCT06717269
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and…		 Enrollment increased: 18 -> 223 participants
2026-07-29 NCT06717269
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and…		 Trial arms changed: 2 -> 7
2026-07-29 NCT06717269
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and…		 date change Primary completion pushed: 2026-04 -> 2026-05-01
2026-07-29 NCT06717269
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and…		 date change Completion moved earlier: 2026-08 -> 2026-05-01
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07516093 Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL B-cell Lymphoma Not Yet Recruiting
Phase 2
NCT07221500 A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine… Chronic Lymphocytic Leukemia (CLL) Recruiting
Phase 1/2
NCT07520006 Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies B-cell Lymphoma Not Yet Recruiting
Phase 1
NCT05107674 A Study of NX-1607 in Adults With Advanced Malignancies Ovarian Cancer, Epithelial Recruiting
NCT04830137 A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies Chronic Lymphocytic Leukemia (CLL) Recruiting
NCT05131022 A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies Chronic Lymphocytic Leukemia (CLL) Recruiting
Disease Areas
Leukemia (5) Chronic Lymphocytic Leukemia (CLL) (5) DLBCL (3) Follicular Lymphoma (2) Mantle Cell Lymphoma (2) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Breast Cancer (1) Triple-Negative Breast Cancer (1) Prostate Cancer (1)
Get alerts when Nurix Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free